相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。One year of pomegranate juice intake decreases oxidative stress, inflammation, and incidence of infections in hemodialysis patients: A randomized placebo-controlled trial
Lilach Shema-Didi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Cardiovascular risk reduction: What do recent trials with rosuvastatin tell us?
Gianna Fabbri et al.
ADVANCES IN THERAPY (2009)
Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1
Mira Rosenblat et al.
JOURNAL OF LIPID RESEARCH (2009)
Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials
HiddoJ Lambers Heerspink et al.
LANCET (2009)
Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities
Wasseem Rock et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2008)
Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPARγ and AP-1 pathway activation
Maayan Shiner et al.
ATHEROSCLEROSIS (2007)
Chronic kidney disease, cardiovascular events, and the effects of perindopril-based blood pressure lowering: Data from the PROGRESS study
Vlado Perkovic et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Pomegranate juice reduces oxidized low-density lipoprotein downregulation of endothelial nitric oxide synthase in human coronary endothelial cells
Filomena de Nigris et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2006)
Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric, oxide
Louis J. Ignarro et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2006)
Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages
Mira Rosenblat et al.
ATHEROSCLEROSIS (2006)
The use of unequal randomisation ratios in clinical trials: A review
JC Dumville et al.
CONTEMPORARY CLINICAL TRIALS (2006)
Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease
MD Sumner et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Clinical epidemiology of cardiovascular disease in chronic kidney disease
K Kundhal et al.
NEPHRON CLINICAL PRACTICE (2005)
Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation
M Aviram et al.
CLINICAL NUTRITION (2004)
Impact of dyslipidemia in end-stage renal disease
SS Prichard
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients
SL Seliger et al.
KIDNEY INTERNATIONAL (2002)
Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure
M Aviram et al.
ATHEROSCLEROSIS (2001)
Atherogenic lipoprotein phenotype in end-stage renal failure: Origin and extent of small dense low-density lipoprotein formation
CJ Deighan et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
分享论文
